US: Pharmaceutical heads urged by congress to curb drug prices

The heads of seven top companies have given evidence before a Senate finance committee on the rising cost of medicines.

The heads of seven top pharmaceutical companies in the United States have been urged to do more to lower drug prices for consumers.

The industry leaders were giving testimony before a Senate finance committee on the rising cost of medicines.

It is expected to be a major issue in the 2020 presidential election campaign.

Al Jazeera’s Alan Fisher reports from Washington, DC.